Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapy.
Guttormsen
A B
AB
Department of Pharmacology, University of Bergen, Norway. Anne.Guttormsen@farm.uib.no
Ueland
P M
PM
Lønning
P E
PE
Mella
O
O
Refsum
H
H
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002528:Cerebellar Neoplasms / Q000097:blood / Q000188:drug therapy; D005493:Folic Acid Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006710:Homocysteine / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000188:drug therapy; D008297:Male; D008527:Medulloblastoma / Q000097:blood / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008875:Middle Aged
D000964:Antimetabolites, Antineoplastic; D005493:Folic Acid Antagonists; D006710:Homocysteine; D008727:Methotrexate